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ABSTRAK 
Trombus di dalam salur vena kava inferior biasanya memberi gambaran kanser hati 
tahap terakhir. Sebelum ini, tidak ada sebarang rawatan yang dapat memberikan 
keputusan yang memberangsangkan. Tetapi dengan kaedah rawatan endovaskular, 
harapan baru mungkin dapat dikecapi. Kami ingin mempertengahkan satu kes 
dimana terapi endovaskular menggunakan AngioJet® rheolytic system (Possis 
Medical, Minneapolis, MN, USA), dapat menunjukkan keputusan yang positif.
Kata kunci: trombektomi, salur vena kava, karsinoma hati, endovaskular
ABSTRACT
The presence of thrombus within the inferior vena cava (IVC) is often a sign of 
advance hepatocellular carcinoma (HCC). Various treatment methods have been 
described with variable and inconclusive results. Now, the advancement of 
endovascular approach offers new possibility as a potential treatment modality.
We discuss the removal of tumour thrombus with catheter directed mechanical 
thrombectomy. IVC tumour secondary HCC was removed by AngioJet® rheolytic 
system (Possis Medical, Minneapolis, MN, USA) with good result. Further work 
should be encouraged to explore the prospect of this technique with other treatment 
modalities.
Keywords: thrombectomy, inferior vena cava, hepatocellular carcinoma, intervention 
radiology, endovascular
INTRODUCTION
Tumour thrombus arising from 
advanced hepatocellular carcinoma 
(HCC) is not an infrequent 
complication. The usual sites of tumour 
thrombus are portal vein, hepatic 
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vein, bile duct and inferior vena cava. 
Various treatment modalities have been 
proposed; including surgical resection, 
transarterial chemoembolization 
(TACE) (Fukuda et al. 2002), targeted 
molecular therapy (Sorafenib), arterial 
and systemic chemotherapy (Okada 
2000), and radiotherapy (conformal 
radiotherapy (Igaki et al. 2008) and 
photon beam therapy (Mizumoto et al. 
2007)). However, no single method has 
been proven to be effective in treating 
this complication (Mizumoto et al. 
2007). 
 The advancement of endovascular 
approach has now open new 
possibilities as a treatment option 
for various pathologies. Catheter 
directed mechanical thrombectomy 
is widely used in coronary artery 
disease, peripheral arterial disease and 
venous thrombosis (Sharifuddin et al. 
2003; Cynamon et al. 2006). To our 
knowledge, endovascular approach to 
remove tumour thrombus has not been 
described previously. 
CASE REPORT
A 85-year-old gentleman presented 
to the surgical out patient clinic with 
complaint of four months history 
of weight loss and vague upper 
abdominal pain. The pain was dull 
in nature and did not radiate to the 
back. Hemodynamically stable, his 
general physical examination revealed 
yellowish discolouration of sclera and 
mild cachexia. The abdomen was soft 
and non-tender with no mass palpable. 
Liver function tests (LFTs) was noted 
to be deranged, with bilirubin 79 mg/
dL, alanine aminotransferase (ALT) 
164 IU/L and alkaline phosphatase 
(ALP) 1120 IU/L. Ultrasound abdomen 
showed dilated intrahepatic ducts 
and common bile duct secondary 
to external compression from the 
enlarged porta hepatis lymph nodes. 
A large, irregular and solid lesion was 
noted to occupy the left lobe of liver 
almost entirely. Endoscopic retrograde 
pancreatography (ERCP) and endobiliary 
stenting was performed to relieve the 
biliary obstruction. Hepatitis screen 
was negative but alpha fetoprotein 
(AFP) was raised at 3520 ng/mL. A 
four phase computed tomography (CT) 
scan of the abdomen confirmed the 
presence of an ill-defined heterogenous 
liver lesion measuring 11cm (width) 
X 7cm (anterior-posterior) X 7.2cm 
(cauda-cranial), occupying segment II, 
III and Iva. The lesion demonstrated 
arterial enhancement and portal as 
well as delayed phase washout of 
contrast material. Thrombosis from the 
left hepatic vein was noted to extend 
into the inferior vena cava. The liver 
function test improved post biliary 
stenting with near normal ALP, ALT and 
bilirubin levels.
 A diagnosis of hepatocellular 
carcinoma with inferior vena cava 
thrombosis was made. However, 
surgical resection of the left lobe of 
liver was deemed inappropriate, given 
the extent of the tumour, patient’s 
age and co-morbidities. A multi-
disciplinary decision was made to treat 
this patient by means of transarterial 
chemoembolisation (TACE) and IVC 
tumour thrombectomy via endovascular 
approach. 
 TACE was performed using a mixture 
of 50 mg Doxorubicin, Lipiodol and 
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drug eluding beads. No immediate 
complication was observed. Almost 
three days later, he started to experience 
pain over the eipigastrium and left 
hypochondrium region. An urgent CT 
scan of the abdomen revealed multiple 
air locules within the infarcted liver 
tumor, suggestive of abscess formation 
post TACE. The liver abscess was 
successfully drained percutaneously 
under ultrasonic guidance and 
intravenous antibiotics commenced 
based on culture and sensitivity report. 
Endovascular thrombectomy of the IVC 
tumor thrombus was performed 3 days 
later. We highlight a novel method of 
IVC thrombectomy using AngioJet® 
rheolytic thrombectomy system. 
 AngioJet® rheolytic thrombectomy 
system consists of an Xpeedior cathether, 
a pump set, and a drive unit. A larger 6F 
Expeedior is used to accommodate the 
larger lumen of an IVC.  The pump set 
and drive unit creates a low-pressure 
zone at the tip of the cathether. This is 
done by emitting a jet of high velocity 
saline solution directed backward from 
the tip of the device outflow channels. 
The low-pressure environment causes 
fragmentation, and clots are aspirated 
through the effluent lumen (Cynamon 
et al. 2006). The pump operates at 8500 
psi, and the speed of the jet can reach 
up to 450km/hr producing a vacuum 
effect of -600mmHg.
 The right femoral vein was 
punctured under aseptic condition and 
a 5Fr pigtail catheter was passed into 
the inferior vena cava below the liver 
level for a diagnostic angiographic run. 
Using an 8F guider and size 0.038Fr 
Roadrunner guide wire, a 6Fr AngioJet® 
catheter was maneuvered to the 
thrombosed segment of the IVC. Series 
of thrombosuctions of 5 seconds were 
performed to a total time of 10 minutes. 
The patient developed macroscopic 
haemaglobinuria post procedure, 
which resolved spontaneously after 36 
hours.
RESULTS
A 50% reduction of filling defect was 
seen immediately post thrombectomy. 
He was discharged well five days 
following the endovascular procedure. 
A repeat CT scan at three months 
showed no further propagation of 
IVC tumor thrombus. However, he 
succumbed to community-acquired 
pneumonia five months after the initial 
treatment of advance hepatocellular 
carcinoma.
DISCUSSION
HCC with IVC tumour thrombosis 
carry an inferior prognosis. If untreated, 
mortality is almost certain at 2-3 months 
from the time of diagnosis (Nagasue et al. 
1984). Transarterial chemoembolization 
(TACE) and intravenous chemotherapy 
have marginal effect on survival 
(Bismuth et al. 1992). Surgical resection 
(hepatectomy with thrombectomy), 
combined with adjuvant hepatic artery 
infusion chemotherapy, is the more 
effective treatment option, although 
it only improves the survival to 7-8 
months (Fukuda et al. 2002). In cases 
of tumour thrombus extending into the 
right atrium, there have been reported 
cases of successful hepatectomy with 
cava-atrial thrombectomy. However, 
the long term survival outcomes were 
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not discussed (Ohwada et al. 2008; 
Leo et al. 2010). Catheter directed 
thrombolysis infusion (CDTI) has also 
been attempted but with no overall 
success (Stambo et al. 2006).
 Recently, photon beam therapy and 
conformal radiotherapy has shown 
promising results as the treatment 
modality for HCC with IVC tumour 
thrombus. A small case series by 
Mizumato et al. (2007) showed survival 
of more than a year upon treatment with 
photon beam. Treatment with conformal 
radiotherapy offers reasonable outcome 
with a median survival of 5.6 months 
(Igaki et al. 2008).
 AngioJet® device is one of the few 
mechanical thrombectomy devices 
available in the market. The others 
include the Oasis (Boston Scientific, 
Natick, MA, USA), Hydrolyser (Cordis 
Europe, Roden, Netherlands), and Clot 
Buster Amplatz Thrombectomy Device 
(ATD, Microvena, White Bear Lake, 
MN, USA). Amplatz thrombectomy 
device has been reported to remove 
thrombus up to 73% at caval level 
(Delomez et al. 2001). Hydrolyser 
device has been successfully used to 
recanalise thrombosed ileofemoral and 
IVC and removing thrombosis around 
IVC filters (Poon et al. 2002). However, 
to the best of our knowledge, removal 
of IVC tumour thrombus has never 
been described previously.
 In this patient, significant amount 
of thrombus was removed, although 
complete thrombectomy was not 
achieved. Total clearance of thrombus 
is very difficult in large vessels like the 
IVC, although Delomez et al. (2001) 
documented angiographic evidence of 
100% removal in their case series.  
 Endovascular thrmboectomy aside, 
localised thrombolysis is widely used 
as adjuvant therapy to improve overall 
venous patency (Sharifuddin et al. 
2003). Localised Urokinase infusion 
has been showed to be effective in 
lysing benign IVC thrombosis (Angle 
et al. 1998). However, Stambo et al. 
(2006) to lyse tumour thrombus using 
Tenectaplase for 24 hours did not show 
any significant improvement.
 The consequences of IVC tumour 
thrombus include IVC obstruction 
syndrome. The symptoms of IVC 
obstruction include progressive ascites, 
scrotal and lower body oedema. 
These symptoms are devastating to 
a patient with end-stage cancer. The 
use of rheolytic thrombectomy has 
the potential to provide symptomatic 
relief to these patients. However, re-
thrombosis of the IVC is common due 
to phlebitis and residual thrombus (Gu 
et al. 1997). Anticoagulant therapy 
would maintain patency in normal 
circumstances, but its role in the 
prevention of tumour re-thrombosis is 
not known.
CONCLUSION
Our experience demonstrates the 
feasibility of rheolytic thrombectomy 
for the removal of IVC tumor thrombus. 
Mechanical thrombectomy could 
reduce tumour load and established 
patency of the IVC. The effect on 
the overall mortality rate is yet to be 
explored. There is scope for further fine 
tuning of the procedure to achieve the 
desired effect. 
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